penicillin-binding protein + _-lactamase inh.

preclin. eff. at 50 mpk SC, 2,000 mpk tolerated

multitarget SBDD + opt. for porin permeability


Entasis Therapeutics

Chemical structure of molecule ETX0462

The Entasis broad-spectrum antibiotic, ETX0462, is both an inhibitor of penicillin-binding proteins (PBPs, the target of beta-lactams) and a beta-lactamase inhibitor (BLI). Reviewer Mike Koehler thought this was a substantial disclosure. “A…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: